 |
PDBsum entry 4x7l
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Transferase/transferase inhibitor
|
PDB id
|
|
|
|
4x7l
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PDB id:
|
|
|
|
| Name: |
|
Transferase/transferase inhibitor
|
|
|
Title:
|
|
Co-crystal structure of perk bound to 4-{2-amino-4-methyl-3-[2- (methylamino)-1,3-benzothiazol-6-yl]benzoyl}-1-methyl-2,5-diphenyl-1, 2-dihydro-3h-pyrazol-3-one inhibitor
|
|
Structure:
|
|
Eukaryotic translation initiation factor 2-alpha kinase 3, eukaryotic translation initiation factor 2-alpha kinase 3. Chain: a. Synonym: prkr-like endoplasmic reticulum kinase,pancreatic eif2-alpha kinase,hspek. Engineered: yes. Mutation: yes
|
|
Source:
|
|
Homo sapiens. Human. Organism_taxid: 9606. Gene: eif2ak3, pek, perk. Expressed in: escherichia coli. Expression_system_taxid: 562
|
|
Resolution:
|
|
|
1.90Å
|
R-factor:
|
0.172
|
R-free:
|
0.193
|
|
|
Authors:
|
|
P.L.Shaffer,A.M.Long,H.Chen
|
|
Key ref:
|
|
A.L.Smith
et al.
(2015).
Discovery of 1H-pyrazol-3(2H)-ones as potent and selective inhibitors of protein kinase R-like endoplasmic reticulum kinase (PERK).
J Med Chem,
58,
1426-1441.
PubMed id:
DOI:
|
|
|
Date:
|
|
|
09-Dec-14
|
Release date:
|
28-Jan-15
|
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
|
Headers
|
|
|
|
References
|
|
|
|
|
|
|
|
Q9NZJ5
(E2AK3_HUMAN) -
Eukaryotic translation initiation factor 2-alpha kinase 3 from Homo sapiens
|
|
|
|
Seq:
Struc:
|
|
|
|
1116 a.a.
260 a.a.*
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Key: |
 |
PfamA domain |
|
|
 |
Secondary structure |
|
|
*
PDB and UniProt seqs differ
at 1 residue position (black
cross)
|
|
|
|
|
|
|
|
|
|
|
|
|
Enzyme class:
|
|
E.C.2.7.11.1
- non-specific serine/threonine protein kinase.
|
|
|
|
|
|
|
Reaction:
|
|
|
1.
|
L-seryl-[protein] + ATP = O-phospho-L-seryl-[protein] + ADP + H+
|
|
2.
|
L-threonyl-[protein] + ATP = O-phospho-L-threonyl-[protein] + ADP + H+
|
|
|
|
|
|
|
L-seryl-[protein]
|
+
|
ATP
|
=
|
O-phospho-L-seryl-[protein]
|
+
|
ADP
|
+
|
H(+)
|
|
|
|
|
|
|
L-threonyl-[protein]
|
+
|
ATP
|
=
|
O-phospho-L-threonyl-[protein]
|
+
|
ADP
|
+
|
H(+)
|
|
|
|
|
|
|
|
|
|
|
|
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
| |
|
|
| |
|
DOI no:
|
J Med Chem
58:1426-1441
(2015)
|
|
PubMed id:
|
|
|
|
|
|
| |
|
Discovery of 1H-pyrazol-3(2H)-ones as potent and selective inhibitors of protein kinase R-like endoplasmic reticulum kinase (PERK).
|
|
A.L.Smith,
K.L.Andrews,
H.Beckmann,
S.F.Bellon,
P.J.Beltran,
S.Booker,
H.Chen,
Y.A.Chung,
N.D.D'Angelo,
J.Dao,
K.R.Dellamaggiore,
P.Jaeckel,
R.Kendall,
K.Labitzke,
A.M.Long,
S.Materna-Reichelt,
P.Mitchell,
M.H.Norman,
D.Powers,
M.Rose,
P.L.Shaffer,
M.M.Wu,
J.R.Lipford.
|
|
|
|
|
| |
ABSTRACT
|
|
|
|
| |
|
|
The structure-based design and optimization of a novel series of selective PERK
inhibitors are described resulting in the identification of 44 as a potent,
highly selective, and orally active tool compound suitable for PERK pathway
biology exploration both in vitro and in vivo.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
 |
 |
|
Links
